The Community Hospice, one of the largest and most established hospice organizations in the nation, will premiere its online "Quality of Life, Not End of Life" program on December 10 at Noon ET. The goal is to raise awareness of the many benefits of hospice care for both patients and their family members. [More]

Hospice workers have watched patients emerge from comas and cling to life long enough to tell someone they love or forgive them. [More]

El Camino Hospital, the hospital of Silicon Valley, today completed its move into the new, technologically and seismically advanced facility. After completing several practice runs led by the activation team, hospital officials report all patients were safely transferred to the new facility. [More]

A partnership between researchers at the University of Leeds and Martin House Children's Hospice has resulted in the world's first comprehensive study of palliative care received by children and young people. [More]

Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter and nine months ended September 30, 2009. [More]

Do pediatric oncologists feel that religion is a bridge or a barrier to their work? Or do they feel it can be either, depending on whether their patients are recovering or deteriorating? A novel Brandeis University study examines these questions in the current issue of Social Problems. [More]

To focus a much-needed, objective light on the ethical concerns regarding the national debate on healthcare reform, the LIFE Institute of Rainbow Hospice and Palliative Care will be hosting a public forum on "Ethics and Healthcare Reform" on Tuesday, November 17th at 7 p.m. at Edison Park Lutheran Church, 6626 N. Oliphant Ave., Chicago. [More]

TomoTherapy Incorporated announced today that the first patients are now being treated with the TomoDirect™ radiation therapy delivery mode at the University of Virginia Cancer Center. The addition of the TomoDirect modality to the TomoTherapy® platform gives clinicians an efficient new option that expands their ability to fight cancer. [More]

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand. [More]

The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness. [More]

The first-ever detailed examination of a country's investment in research on childhood and adolescent cancers was released today by the Canadian Cancer Research Alliance (CCRA) and the Canadian Partnership Against Cancer (the Partnership). [More]

America's foremost authorities on aging will share the latest information on "death panels," anti-aging medicine, health care reform, and other current topics at The Gerontological Society of America's upcoming 62nd Annual Scientific Meeting. This four day event - the country's largest interdisciplinary conference in the field of aging - will take place from November 18 to 22 in Atlanta, GA. Media representatives can register free of charge. [More]

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone. [More]

Questions about end of life are as old as humanity, yet they can be new and overwhelming when someone we care about is dying. [More]

Two studies published in the New England Journal of Medicine find that some medical care, especially at the end of life, may be a poor choice for feeble seniors. They also show the importance of palliative care over aggressive treatment for certain patients. [More]